ArticleJournal of arrhythmia2026
Clinical Significance of Patient Disease Awareness in Atrial Fibrillation: Risk Profiles and Post-Ablation Outcomes.
Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The clinical relevance of patient disease awareness on risk factor control and clinical outcomes after atrial fibrillation (AF) ablation remains incompletely understood. Methods: We conducted a prospective cohort study enrolling 133 patients undergoing an initial AF ablation. Disease awareness was assessed using the Jessa Atrial Fibrillation Knowledge Questionnaire (JAKQ) -a 16-item instrument comprising 8 questions on general AF knowledge and 8 questions on oral anticoagulant therapy-administered before and 1 year after ablation. We divided them into the poor disease awareness group and good disease awareness group according to the median value (75%) of the JAKQ score about AF in general and compared the baseline patient characteristics and the 1-year changes in the JAKQ score, blood pressure, laboratory data, echocardiographic parameters, and AF/atrial tachycardia (AT) recurrence rate between the groups. Results: Forty-two (31.6%) patients were classified as having a poor disease awareness (< 75% of the JAKQ score about AF in general), which was associated with hypertension, diabetes, dyslipidemia, and greater left atrial volume (LAV). These trends in the poor disease awareness group remained unchanged 1 year after the ablation. During the 25.3 [15.7-34.9] month follow-up, the AF/AT recurrence rate was significantly higher in the poor disease awareness than good disease awareness group (23.8% vs. 7.7%; Conclusions: Poor disease awareness was linked to lifestyle-related diseases, greater LAV before and even 1 year after the ablation, making it a potential surrogate marker for AF/AT recurrence. These findings highlight the clinical significance of disease awareness for AF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.